title: Newer non-oral hormonal contraception.
authors: Family Planning NSW, Sydney, NSW 2131, Australia. deborahb@fpnsw.org.au
authors: Deborah
authors: D
authors: Bateson
authors: Kathleen
authors: K
authors: McNamee
authors: Paula
authors: P
authors: Briggs
mesh_terms: D000279:Administration, Cutaneous; D003271:Contraceptive Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D003274:Contraceptive Devices, Female; D017135:Desogestrel / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D004343:Drug Implants; D016903:Drug Monitoring; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000008:administration & dosage* / Q000009:adverse effects; D009644:Norgestrel / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D012449:Safety; D016896:Treatment Outcome
chemical_list: D003271:Contraceptive Agents, Female; D004338:Drug Combinations; D004343:Drug Implants; C511292:Ortho Evra; C044815:etonogestrel; D009644:Norgestrel; D004997:Ethinyl Estradiol; D016912:Levonorgestrel; D017135:Desogestrel